Net income
−$5.4M
−209.1% vs same quarter last year
EPS, diluted
−$0.60
−140% vs same quarter last year
Operating cash flow
−$3.1M
−81.3% vs same quarter last year
Operating income
−$5.5M
−189.9% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | - | −$7.2M |
| FY24 | - | −$6.2M |
| FY23 | - | −$8.4M |
| FY22 | - | −$17.5M |
| FY21 | $0 | −$13.3M |
| FY20 | $328.8K | −$6.4M |
| FY19 | $0 | −$1.5M |
| FY18 | $211.8K | −$5M |
| FY17 | $228.3K | −$5M |
| FY16 | $1.3M | −$5M |
| FY15 | $758.7K | −$2.8M |
| FY14 | $372.1K | −$8.4M |
| FY13 | $545.5K | −$14.5M |
| FY12 | $286.1K | −$5.5M |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | - | - | - |
| FY24 | - | - | - |
| FY23 | - | - | - |
| FY22 | - | - | - |
| FY21 | - | - | - |
| FY20 | 94.6% | −1946.7% | −1935.3% |
| FY19 | - | - | - |
| FY18 | 37.1% | −2397.1% | −2378.6% |
| FY17 | −9.5% | −2288.6% | −2203.7% |
| FY16 | 35.6% | −386% | −395.2% |
| FY15 | 23.4% | −571.9% | −374.7% |
| FY14 | −26.1% | −1536.7% | −2267.9% |
| FY13 | 89.5% | - | −2657.5% |
| FY12 | −49% | - | −1932.9% |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | - |
| FY24 | - |
| FY23 | −$6.6M |
| FY22 | −$12.3M |
| FY21 | −$13.7M |
| FY20 | −$5M |
| FY19 | −$1.3M |
| FY18 | −$5M |
| FY17 | −$5M |
| FY16 | −$4.9M |
| FY15 | −$4.7M |
| FY14 | −$4.5M |
| FY13 | −$2.8M |
| FY12 | −$4M |
- Edesa Biotech
- Healthcare median
Show the numbers
| Year | Edesa Biotech | Healthcare median |
|---|---|---|
| FY25 | - | −30.6% |
| FY24 | - | −47% |
| FY23 | - | −58% |
| FY22 | - | −80.4% |
| FY21 | - | −71.8% |
| FY20 | −1935.3% | −62.2% |
| FY19 | - | −46.2% |
| FY18 | −2378.6% | −49.6% |
| FY17 | −2203.7% | −45.9% |
| FY16 | −395.2% | −36% |
| FY15 | −374.7% | −37.8% |
| FY14 | −2267.9% | −35.5% |
| FY13 | −2657.5% | −37.1% |
| FY12 | −1932.9% | −29.1% |